Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/22567
Title: Pertussis vaccination during pregnancy in Belgium: Follow-up of infants until 1 month after the fourth infant pertussis vaccination at 15 months of age
Authors: Maertens, Kirsten
Cabore, Raissa Nadege
Huygen, Kris
Vermeiren, Sandra
HENS, Niel 
Van Damme, Pierre
Leuridan, Elke
Issue Date: 2016
Publisher: ELSEVIER SCI LTD
Source: VACCINE, 34(31), p. 3613-3619
Abstract: Vaccination of pregnant women with a pertussis containing vaccine is a recommended strategy in some industrialized countries, to protect young infants from severe disease. One of the effects of the presence of high titers of passively acquired maternal antibodies in young infants is blunting of immune responses to infant vaccination. We present infant immune responses to a fourth pertussis containing vaccine dose at 15 months of age, as a follow-up of previously presented data. In a prospective cohort study, women were either vaccinated with an acellular pertussis vaccine (Boostrix (R)) during pregnancy (vaccine group) or received no vaccine (control group). All infants were vaccinated with Infanrix Hexa (R) according to the standard Belgian vaccination schedule (8/12/16 weeks, 15 months). We report results from blood samples collected before and 1 month after the fourth vaccine dose. Immunoglobulin G (IgG) antibodies against pertussis toxin (PT), filamentous hemagglutinin (FHA), pertactin (Pm), tetanus toxoid (TT) and diphtheria toxoid (DT) were measured using commercially available ELISA tests. Antibody levels were expressed in International Units per milliliter. Demographic characteristics were similar in the vaccine and control group. Before the fourth vaccine dose, significantly lower antibody titers were measured in the vaccine group compared to the control group for anti-Pm IgG (p = 0.003) and anti-DT IgG (p = 0.023), with a steep decay of antibody titers since post-primary vaccination. One month after the fourth dose, antibody titers were only significantly lower in the vaccine group for anti-PT IgG (p = 0.006). For all antigens, there was a rise in antibody titer after the fourth vaccine dose. The present results indicate still a minor blunting effect 1 month after a fourth vaccine dose for anti-PT antibodies. However, a good humoral immune response on all measured antigens was elicited in both groups of children. The clinical significance of such blunting effect is yet unknown. (C) 2016 Elsevier Ltd. All rights reserved.
Notes: [Maertens, Kirsten; Vermeiren, Sandra; Van Damme, Pierre; Leuridan, Elke] Univ Antwerp, Ctr Evaluat Vaccinat, Vaccine & Infect Dis Inst, Univ Pl 1, B-2610 Antwerp, Belgium. [Cabore, Raissa Nadege; Huygen, Kris] Natl Reference Ctr Toxigen Corynebacteria, Natl Reference Ctr Bordetella, Serv Immunol, Sci Inst Publ Hlth WIV ISP, Brussels, Belgium. [Hens, Niel] Hasselt Univ, Interuniv Inst Biostat & Stat Bioinformat I BIOST, Hasselt, Belgium. [Hens, Niel] Univ Antwerp, Vaccine & Infect Dis Inst, Ctr Hlth Econ Res & Modeling Infect Dis, B-2610 Antwerp, Belgium.
Keywords: Pertussis; Vaccination in pregnancy; Maternal antibodies; Blunting;pertussis; vaccination in pregnancy; maternal antibodies; blunting
Document URI: http://hdl.handle.net/1942/22567
ISSN: 0264-410X
e-ISSN: 1873-2518
DOI: 10.1016/j.vaccine.2016.04.066
ISI #: 000378955600009
Rights: © 2016 Elsevier Ltd. All rights reserved
Category: A1
Type: Journal Contribution
Validations: ecoom 2017
Appears in Collections:Research publications

Files in This Item:
File Description SizeFormat 
maertens 1.pdf
  Restricted Access
Published version986.86 kBAdobe PDFView/Open    Request a copy
Maertens et al. Vaccine 2016. Preprint.pdfPeer-reviewed author version464.29 kBAdobe PDFView/Open
Show full item record

SCOPUSTM   
Citations

42
checked on Sep 3, 2020

WEB OF SCIENCETM
Citations

69
checked on Apr 22, 2024

Page view(s)

56
checked on Sep 7, 2022

Download(s)

154
checked on Sep 7, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.